CAMBRIDGE, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a biotechnology company pioneering the development of a new class of programmable ...

View Omega Therapeutics, Inc. (OMGA) current and estimated P/E ratio data provided by Seeking Alpha.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

After hours: September 19 at 6:13 PM EDT Loading Chart for OMGA ...

We currently have no OMGA Stock Split History on this stock.

As of September 13, 2024, Omega Therapeutics Inc had a $68.4 million market capitalization, putting it in the 32nd percentile of companies in the Biotechnology & Medical Research industry. Omega ...